Gabelli Funds LLC Sells 3,060 Shares of Cigna Group $CI

Gabelli Funds LLC cut its position in Cigna Group (NYSE:CI) by 6.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 47,360 shares of the health services provider’s stock after selling 3,060 shares during the period. Gabelli Funds LLC’s holdings in Cigna Group were worth $12,633,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Public Employees Retirement System of Ohio grew its holdings in shares of Cigna Group by 1.0% during the first quarter. Public Employees Retirement System of Ohio now owns 119,968 shares of the health services provider’s stock valued at $32,001,000 after buying an additional 1,241 shares during the last quarter. Caxton Associates LLP acquired a new stake in shares of Cigna Group in the 1st quarter worth about $2,051,000. Gibbs Wealth Management raised its holdings in shares of Cigna Group by 137.3% in the 1st quarter. Gibbs Wealth Management now owns 6,965 shares of the health services provider’s stock worth $1,858,000 after acquiring an additional 4,030 shares during the last quarter. Sei Investments Co. lifted its position in Cigna Group by 83.6% in the 1st quarter. Sei Investments Co. now owns 865,893 shares of the health services provider’s stock valued at $230,976,000 after acquiring an additional 394,294 shares in the last quarter. Finally, Keynote Financial Services LLC boosted its stake in Cigna Group by 3.0% during the 1st quarter. Keynote Financial Services LLC now owns 3,058 shares of the health services provider’s stock valued at $816,000 after purchasing an additional 89 shares during the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of analysts have commented on CI shares. Morgan Stanley boosted their price objective on Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a report on Wednesday, May 20th. Cantor Fitzgerald lifted their target price on Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a research report on Friday, May 1st. Guggenheim upped their price target on Cigna Group from $334.00 to $338.00 and gave the stock a “buy” rating in a report on Monday, May 4th. Barclays lowered Cigna Group from an “overweight” rating to an “equal weight” rating and lowered their price target for the company from $310.00 to $304.00 in a research report on Tuesday, May 26th. Finally, Wells Fargo & Company raised their price objective on Cigna Group from $300.00 to $305.00 and gave the company an “equal weight” rating in a research note on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $338.80.

Insider Activity

In other Cigna Group news, CEO David Cordani sold 201,878 shares of the business’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the transaction, the chief executive officer directly owned 34,337 shares in the company, valued at $10,054,560.34. The trade was a 85.46% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the sale, the chief accounting officer directly owned 2,368 shares in the company, valued at $707,108.48. This trade represents a 27.52% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 0.60% of the company’s stock.

Cigna Group Price Performance

Cigna Group stock opened at $290.06 on Monday. Cigna Group has a 52 week low of $239.51 and a 52 week high of $315.47. The company’s 50 day moving average price is $286.05 and its two-hundred day moving average price is $280.76. The stock has a market cap of $76.73 billion, a P/E ratio of 12.30, a P/E/G ratio of 1.12 and a beta of 0.29. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The company had revenue of $68.52 billion during the quarter, compared to the consensus estimate of $66.29 billion. During the same period last year, the business posted $6.74 earnings per share. Cigna Group’s revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, equities analysts predict that Cigna Group will post 30.39 earnings per share for the current year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be issued a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date is Tuesday, September 8th. Cigna Group’s dividend payout ratio (DPR) is 26.45%.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.